Regeneron Pharmaceuticals Inc. (REGN34)
Market Closed
10 Aug, 19:55
B3 B3 Primary R$
68. 53
+1.94
+2.9134%
R$
362.64B Market Cap
24.52 P/E Ratio
0.22% Div Yield
1,556 Volume
42.79 Eps
R$ 66.59
Previous Close Want to track REGN34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Regeneron Pharmaceuticals Inc. (REGN34) Statistics
Valuation metrics
Market Cap 362.64B
Enterprise value -2.85B
Trailing P/E (ttm) 15.44
Forward P/E -
PEG ratio -1.98
Price/Sales (ttm) 22.52
Price/Book (mrq) 2.06
Enterprise Value/Revenue -0.04
Enterprise Value/EBITDA -0.13
Overview
Shares outstanding 105.02M
Float 97.67M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.78K
Average volume (90 days) 1.35K
Price summary
52-Week low 49.24
52-Week high 73.33
Beta 0.3
50-Day moving average 62.28
200-Day moving average 60.98
Dividends and splits
Forward annual dividend rate 0.22
Forward annual dividend yield 0.0041%
Trailing annual dividend rate 0.22
Trailing annual dividend yield 0.0042%
5-Year annual dividend yield -
Payout ratio 0.06
Dividend Date -
Ex-Dividend Date -
Last split factor 12:1
Last split Date 28 Nov 2022
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.3%
Operating margin 0.21%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.15%
Income Statement
Revenue (ttm) 74.82B
Revenue per share (ttm) 2.44
Quarterly revenue growth (yoy) 0.19%
Gross profit (ttm) 32.83B
EBITDA 5.12B
Net income to common (ttm) 22.18B
Diluted EPS (ttm) 3.46
Quarterly earnings growth (yoy) -0.1%
Balance Sheet
Total cash (mrq) 43.9B
Total cash per share (mrq) 86.04
Total debt (mrq) 13.57B
Total Debt/Equity (mrq) 8.61
Current ratio (mrq) 3.56%
Book value per share (mrq) 25.93
Cash Flow
Cash flow statement 25.14B
Levered free cash flow (LFCF) 16.41B
